


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.50%
-6.33%
-12.08%
-2.75%
-21.44%
AEMD
Aethlon Medical Inc.
$1.76
AEMD Price Performance
$2.33 (-24.46%)
$4.03 (-56.33%)
$0.73 (+141.10%)
$0.39 (+351.28%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
AEMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AEMD Street Sentiment is bullish and have negative views on the near-term outlook
AEMD has Medium risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
What is AEMD current stock price?
What are AEMD stock strengths?
What is AEMD Risk Level?
What is AEMD market cap and volume?
What is AEMD current Stock IQ?
Should I buy AEMD stock right now?
Is AEMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for AEMD?
What does a 'Strong Sell' rating mean for AEMD?
What factors influence AEMD's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
AEMD
Aethlon Medical Inc.
Current Price
$1.76

AEMD Price Performance
$2.33 (-24.46%)
$4.03 (-56.33%)
$0.73 (+141.10%)
$0.39 (+351.28%)
AEMD Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
AEMD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AEMD Street Sentiment is bullish and have negative views on the near-term outlook
AEMD has Medium risk level
Risk Indicators
AEMD Stock IQ
Stock Insights
Not Enough Information
AEMD Latest Analysis
AEMD: Advancing Oncology Trial. Seeking to Simplify - Potentially Broaden – Device Application. By Cohort 2 participants being treated with queue building for patient participation in trialAethlon Medical (NASDAQ:AEMD) announced FY 3Q (quarter ended December 31 2025) results and provided a business update last week. The companys primary focus is on researching lead asset the Hemopurifier® therapeutic blood filtration system as a potential treatment in oncology. The Hemopurifier is an investigati
Wed Feb 18, 2026
Aethlon Medical GAAP EPS of -$2.45 misses by $0.03.
Thu Feb 12, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AEMD Stock trends
AEMD Stock performance
AEMD Stock analysis
AEMD investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.